RALUDOTATUG

UNII:	Y2Y9AP91JZ
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	RALUDOTATUG
GSRS Full Record:	Y2Y9AP91JZ i

2610074-56-9
Immunoglobulin G1, anti-(human cadherin 6) (human-Rattus norvegicus monoclonal MABU-9014a γ1-chain), disulfide with human-Rattus norvegicus monoclonal MABU-9014a κ-chain, dimer
RALUDOTATUG [USAN]
Raludotatug
gamma1 heavy chain humanized (1-452) [VH (Homo sapiens IGHV1-3*01 (86.7%) -(IGHD) -IGHJ4*01(93.3%), CDR-IMGT [8.8.15] (26-33.51-58.97-111))(1-122) -Homo sapiens IGHG1*03, G1m3, nG1m1 (CH1R120 (219) (123-220), hinge 1-15 (221-235), CH2(236-345), CH3 E12 (361), M14 (363) (346-450), CHS(451-452)) (123-452)], (225-213')-disulfide with kappa light chain humanized (1'-213') [V-KAPPA (Homo sapiens IGKV1-39*01(86%) -IGKJ1*01 (91.7%), CDR-IMGT [6.3.8] (27-32.50-52.89-96)) (1'-106')-Homo sapiens IGKC*01 (100%), Km3 A45.1 (152), V101 (190) (107'-213')], dimer (231-231'': 234-234'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa
immunoglobulin G1-kappa, anti-[Homo sapiens CDH6(cadherin 6, K-cadherin (foetal kidney), cadherin 6 type 2)], humanized monoclonal antibody
raludotatug [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RALUDOTATUG

Synonyms and Mappings

Resources